1. OC-0060 Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia. (August 2021) Authors: Clark, M.A.; Slotman, B.; Ozyar, E.; Kim, M.; Itami, J.; Tallet, A.; Debus, J.; Pfeffer, R.; Gentile, P.; Hama, Y.; Andratschke, N.; Azria, D.; Camilleri, P.; Belka, C.; Quivrin, M.; Kim, B.; Pedersen, A.; van Overeem Felter, M.; Young, K.; Kim, J.H. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1467 Pegylated Liposomal Mitomycin C Lipidic Prodrug and Palliative Radiotherapy– a Phase 1B Study. (May 2022) Authors: Sapir, E.; Pfeffer, R.; Wygoda, M.; Levy, A.; Corn, B.; Ohana, P.; Gabizon, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1112 Real-time online matching in high dose treatments: Do RTTs perform as well as physicians?. (April 2019) Authors: Levin, D.; Grinfeld, G.; Greenberg, V.; Lipsky, Y.; Zalmanov-Faermann, S.; Tova, Y.; Pfeffer, R. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗